264 related articles for article (PubMed ID: 8812733)
21. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy.
Chen YQ; Rafi MA; de Gala G; Wenger DA
Hum Mol Genet; 1993 Nov; 2(11):1841-5. PubMed ID: 8281145
[TBL] [Abstract][Full Text] [Related]
22. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.
Furuya H; Kukita Y; Nagano S; Sakai Y; Yamashita Y; Fukuyama H; Inatomi Y; Saito Y; Koike R; Tsuji S; Fukumaki Y; Hayashi K; Kobayashi T
Hum Genet; 1997 Sep; 100(3-4):450-6. PubMed ID: 9272171
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
24. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
[TBL] [Abstract][Full Text] [Related]
26. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
28. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
29. Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
Weinstock NI; Shin D; Dhimal N; Hong X; Irons EE; Silvestri NJ; Reed CB; Nguyen D; Sampson O; Cheng YC; Lau JTY; Bongarzone ER; Kofler J; Escolar ML; Gelb MH; Wrabetz L; Feltri ML
Neuron; 2020 Jul; 107(1):65-81.e9. PubMed ID: 32375064
[TBL] [Abstract][Full Text] [Related]
30. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
[TBL] [Abstract][Full Text] [Related]
31. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
32. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
33. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease.
Zizioli D; Guarienti M; Tobia C; Gariano G; Borsani G; Bresciani R; Ronca R; Giacopuzzi E; Preti A; Gaudenzi G; Belleri M; Di Salle E; Fabrias G; Casas J; Ribatti D; Monti E; Presta M
Biochim Biophys Acta; 2014 Apr; 1842(4):665-75. PubMed ID: 24463171
[TBL] [Abstract][Full Text] [Related]
35. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
36. Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.
Rafi MA; Rao HZ; Luzi P; Curtis MT; Wenger DA
Mol Ther; 2012 Nov; 20(11):2031-42. PubMed ID: 22850681
[TBL] [Abstract][Full Text] [Related]
37. Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells.
Strazza M; Luddi A; Carbone M; Rafi MA; Costantino-Ceccarini E; Wenger DA
Mol Genet Metab; 2009 May; 97(1):27-34. PubMed ID: 19217332
[TBL] [Abstract][Full Text] [Related]
38. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.
Lee WC; Kang D; Causevic E; Herdt AR; Eckman EA; Eckman CB
J Neurosci; 2010 Apr; 30(16):5489-97. PubMed ID: 20410102
[TBL] [Abstract][Full Text] [Related]
40. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.
Rafi MA; Luzi P; Chen YQ; Wenger DA
Hum Mol Genet; 1995 Aug; 4(8):1285-9. PubMed ID: 7581365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]